Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-26 @ 9:42 PM
Study NCT ID:
NCT01314833
Status:
COMPLETED
Last Update Posted:
2020-05-19
First Post:
2011-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Sponsor:
Fudan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-09
First Submit QC Date:
None
Study First Post Date:
2011-03-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-17
Last Update Post Date:
2020-05-19
Last Update Post Date Type:
ACTUAL